Taking these into account, it could be hypothesized that hypomethylating agents-induced CD4+HLA-G+FOXP3-T cells in vitro would be adoptive cellular immunotherapy against acute graft-versus-host disease. The gene discussed is HLA-G; the disease is graft versus host disease.